NodeAI Wins Falcons' Fortunes for AI Lung Cancer Diagnostics
NodeAI, a startup based in Hamilton, Ontario, has won the Falcons' Fortunes 2025 competition, securing the $100,000 Ernsting Entrepreneurship award. Announced in a press release, the company was recognized for its innovative use of artificial intelligence to enhance the speed and accuracy of diagnosing and staging non-small cell lung cancer (NSCLC).
The award was presented to Dr. Waƫl Hanna, co-founder and Chief Medical Officer of NodeAI, during the annual event hosted by FACIT Inc. The competition, which focuses on oncology innovations, featured six entrepreneurs from Ontario pitching their groundbreaking technologies. NodeAI's solution aims to fill a critical gap in lung cancer diagnostics, potentially improving treatment decisions and patient outcomes.
FACIT's Falcons' Fortunes event is a key platform for early-stage ventures in Ontario, providing essential pre-seed capital to help startups establish a strong foundation in the region. The event also included a keynote from Dr. Thomas Hudson, a notable figure in oncology research and commercialization.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 22 Aqurio Named Finalist for 2026 AI Startup of the Year Sep 22 Tsingke Introduces Validation Workflow for AI Designed Proteins Sep 22 QC Healthcare Partners With Sanguina for AI Blood Health Screening Sep 22 RIVANNA Files 100th Patent for Ultrasound AI Sep 22 Ultima Genomics Platform Selected for Precure's One Million Sample DatasetLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
HealthCatalyst Northwest Arkansas Names Seven Startups for Community Pilots
Atman Health Wins ARPA-H Award to Build Heart Failure AI
Lancium and NVIDIA Partner on AI Factory Campuses
Jetstream Venture Fund Invests in ImageAiD and Moonrise Medical
Norbert Health Raises $14 Million for Robotic Nursing Assistants
Daily AI Brief: the AI news that matters, in your inbox.